Abstract Details

Title Effects of the NR2B Subunit Selective NMDA Receptor Antagonist CP-101,606 on Motor Disability in Parkinson[apos]s Disease (PD)

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
John G. Nutt, MD, FAAN (Oregon Health & Science University)	No disclosure on file
Penelope Hogarth, MD (Oregon Health & Science UniversityMolecular & Medical Genetics Dept)	No disclosure on file
Joana C. Dias, MD (Clinica Sandri)	No disclosure on file
	No disclosure on file
Michael Krams, MD (Pfizer ClinSci CNS)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Steven A. Gunzler, MD, FAAN (Parkinson's and Movement Disorders Ctr, University Hospitals)	Dr. Gunzler has received research support from NIH/NINDS. Dr. Gunzler has received research support from Parkinson's Foundation. The institution of Dr. Gunzler has received research support from UCB. The institution of Dr. Gunzler has received research support from Bial.
Jaren W. Landen, PhD (Biogen)	No disclosure on file

��ɫ��